Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure (Q40363090)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 October 2005

Language	Label	Description	Also known as
English	Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure	scientific article published on 10 October 2005

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure (English)

1 reference

Europe PubMed Central

19 September 2017

4

object named as

Shinichi Oka

1 reference

Europe PubMed Central

19 September 2017

author name string

Hiroyuki Gatanaga

1

1 reference

Europe PubMed Central

19 September 2017

Atsuko Hachiya

2

1 reference

Europe PubMed Central

19 September 2017

Satoshi Kimura

3

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

10 October 2005

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

344

1 reference

Europe PubMed Central

19 September 2017

2

1 reference

Europe PubMed Central

19 September 2017

354-362

1 reference

Europe PubMed Central

19 September 2017

Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

"All-in-One Assay", a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Human immunodeficiency virus reverse transcriptase and protease sequence database

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

In vitro induction of human immunodeficiency virus type 1 variants resistant to phosphoralaninate prodrugs of Z-methylenecyclopropane nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.09.005

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40363090&oldid=1896200655"